Prognostic models in primary central nervous system lymphoma patients: A systematic review

Crit Rev Oncol Hematol. 2021 May:161:103341. doi: 10.1016/j.critrevonc.2021.103341. Epub 2021 Apr 15.

Abstract

Over the last decade, several prognostic models have been proposed for primary central nervous system lymphoma (PCNSL), but consensus on the optimal model for these patients is absent or lacking. This study aims to review available prognostic models for PCNSL and discuss their prognostic features. A comprehensive literature search performed in Pubmed/Embase identified ten studies with a variable number of analysed patients (range 32-3453), which proposed 12 prognostic models. Age and performance status were the most important prognostic factors in PCNSL and an integral part of the majority of the proposed models. However, there is no universally accepted prognostic model for PCNSL owning to a number of limitations such as a small number of patients, limited samples obtained for genetic analysis, retrospective nature of studies, single centre studies, and lack of validation. Future multicentre studies are necessary to determine the optimal prognostic model for PCNSL by combining different prognostic markers of significance.

Keywords: Central nervous system; Lymphoma; Model; Prognosis.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Central Nervous System
  • Central Nervous System Neoplasms* / diagnosis
  • Central Nervous System Neoplasms* / therapy
  • Humans
  • Lymphoma, Non-Hodgkin*
  • Prognosis
  • Retrospective Studies